查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479069

军团菌测试市场：依测试类型、依应用、依最终用户、依地区、机会、预测，2017-2031 年

Legionella Testing Market Assessment, By Test Type, By Applications, By End-User, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 236 Pages | 商品交期: 3-5个工作天内

价格

全球军团菌检测市场规模预计将从 2023 年的 3.513 亿美元成长到 2031 年的 6.27 亿美元，在 2024 年至 2031 年的预测期内复合年增长率为 7.51%。退伍军人病、肺炎和庞蒂亚克热的盛行率不断上升，人们对军团菌检测在感染预防中的重要性的认识不断提高，以及市场参与者加强其产品组合的努力，推动了市场的成长。

军团菌在热水浴缸、冷却水塔和管道网路等水系统中大量繁殖。这就是为什么包括酒店、商业房地产、医疗保健和製造业在内的各个行业都在投资定期军团菌检测。因此，商业房地产行业正在各个地区扩张，为市场提供了利润丰厚的成长机会。预计2024年印度商业房地产行业将成长至少7-8%。

各个监管机构和政府正在加强采取举措，例如引入严格的指导方针和法规，以促进定期水质检测，这是军团菌检测市场的全球主要趋势之一。监管标准的存在确保了水管理计画的实施，以降低污染风险，特别是在疗养院、饭店、医院和工业区周围的地区。

其他推动市场扩张的因素包括免疫学、分子生物学和微生物学的进步。这些领域的进步有助于开发更特异、更灵敏、更快速的军团菌测试。它还可以及早发现军团菌污染，并确保各机构及时干预以防止疫情爆发。由于加大力度确保游客安全，饭店业的快速扩张也对市场扩张产生了正面影响。

该报告研究了全球军团菌测试市场，并提供了市场概述，包括依测试类型、应用、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章研究方法论

第二章 专案范围与定义

第三章执行摘要

第四章 2017-2031 年全球军团菌检测市场展望

  • 市场规模及预测
  • 依测试类型
  • 依用途
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第五章 全球军团菌检测市场展望（依地区，2017-2031）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章 2023 年市场规划

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

第九章 监理架构与创新

第十章 主要与企业状况

第11章价格分析

第十二章案例研究

第十三章 主要进入者展望

  • BioMerieux SA
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE
  • Becton, Dickinson and Company
  • Qiagen NV
  • Aquacert Ltd.
  • Merck KgaA
  • Abbott Laboratories
  • Pro Lab Diagnostics Inc.
  • IDEXX Laboratories, Inc.

第十四章 战略建议

第十五章 查询及免责声明

Product Code: MX11320

Global legionella testing market is projected to witness a CAGR of 7.51% during the forecast period 2024-2031F, growing from USD 351.3 million in 2023 to USD 627 million in 2031F. The market growth is boosted by the increasing prevalence of legionellosis, pneumonia, and Pontiac fever, growing awareness about the importance of legionella testing in preventing infections, and rising efforts by various market players towards enhancing their product portfolio.

The legionella bacteria thrive in water systems such as hot tubs, cooling towers, and plumbing networks. Therefore, various industries, including hospitality, commercial real estate, healthcare, and manufacturing, are investing in regular legionella testing as they understand the activity's benefits and crucial role in maintaining the safety and health of the customers and occupants. Hence, expanding the commercial real estate sector in various regions provides lucrative growth opportunities for the market. India's commercial real estate sector is expected to grow at least 7-8% in 2024.

Various regulatory bodies and governments are taking increasing initiatives, including introducing stringent guidelines and regulations to promote regular water testing, which are among the key global legionella testing market trends. The presence of regulatory standards ensures that water management plans are implemented to mitigate the risk of contamination, especially in areas surrounding nursing homes, hotels, hospitals, and industrial areas.

Other factors bolstering the market expansion include immunology, molecular biology, and microbiology advancements. Advancements in these arenas have aided in the development of legionella testing methods that are more specific and sensitive as well as rapid. They also allow for early detection of contamination by legionella, ensuring prompt intervention by various agencies to prevent outbreaks. The rapid expansion of the hospitality sector is also positively influencing market expansion due to an increase in efforts towards ensuring the safety of the tourists.

Increase in Legionella Related Illnesses Boosts the Global Legionella Testing Market Demand

The legionella bacteria are found in water systems and reservoirs and are responsible for causing various diseases, including Pontiac fever and pneumonia. Legionnaires' disease has an incubation period of two to ten days. According to the estimates of the World Health Organization (WHO), 60-70% of the reported cases are of males, and 75-80% are over fifty years of age. The increasing prevalence of hospital-acquired legionella is further propelling market demand. Regular testing helps identify the source of infection and prevent outbreaks. Legionella is consumed by amoeba, multiplying from within before exploding, resulting in an outbreak. Due to this ongoing testing, combating the potential bacterial problems becomes essential. Legionella bacteria tend to grow in slime and biofilms on the surface of streams, lakes, and rivers. Low levels of the organism can colonize different water sources, growing in high concentrations under appropriate conditions.

Technological Advancements Boost Global Legionella Testing Market Growth

Various organizations and research institutes are investing in the development of advanced methods and devices to detect legionella due to the increasing prevalence of the various diseases caused by the bacteria. The traditional methods of monitoring the temperature of the water outlets have been seen to be economically inefficient, manual, and resource-intensive. Thus, the independent internet of things network operator Heliot Europe and Sigfox operators have initiated a partnership with Cistermiser for developing their LinkThru Temperature Monitoring Unit (TMU) devices. These devices have been developed for connecting to Heliot's Sigfox-0G network for IoT. After the device is connected to the pipework system, it harnesses internet of things technology for monitoring the flow and temperature of the water. The data is then captured in appropriate formats for regulators, allowing building owners to ensure compliance with HSG274 regulation in order to reduce the risk of legionella and other pathogens that are waterborne.

North America Accounts for Significant Market Share

The presence of an established healthcare infrastructure, strong water testing regulations, and increasing awareness about the disease are supporting the growth of the North America legionella testing market. The requirement for legionella testing is also propelling due to increasing vulnerability to infection and the expansion of the geriatric population. The regulatory agencies in the region, including the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC), are implementing stringent regulations for monitoring water systems and guidelines for testing for legionella contamination. The presence of various leading market players in North America is further supporting the growth of the market in the region as they are increasing their efforts to introduce legionella testing kits to their portfolios. For instance, in 2021, Thermo Fisher introduced the qualyfast DNA extraction kit for detecting Legionella in clear water samples. The qualyfast Legionella PCR range provides environmental testing laboratories with a workflow that is capable of delivering accurate results within hours.

Urinary Antigen Test Accounts for Significant Global Legionella Testing Market Share

Urinary antigen tests allow for rapid identification of infections, allowing for earlier adoption of preventive measures and targeted therapies. The urinary antigen test is deployed for detecting the molecules of legionella bacterium in urine. Advancements in urinary antigen testing technologies to ensure the provision of reliable results in a time efficient manner are supporting segment expansion. The easy-to-perform and rapid nature of the test as compared to conventional methods is further bolstering their popularity. According to the article Evaluation of Four Lateral Flow Assays for the Detection of Legionella Urinary Antigen, published in Microorganisms journal, the overall specificity and sensitivity of legionella urinary antigen tests are 90.0-94.9% and 53.9-61.5%, respectively. The high specificity and sensitivity offered are propelling the utilization of urinary antigen test and augmenting the expansion of the segment.

Water Treatment Plants Expected to Witness Significant Growth

The rising requirement for legionella testing from water treatment plants is boosting the global legionella testing market size. The presence of legionella in commercial buildings and workplaces can be catastrophic, making testing for legionella an essential requirement. The bacteria are found in water and are inhaled through airborne droplets that are often created by cold or hot water systems. If inhaled, it can lead to legionnaires disease, one of the most fatal types of pneumonia. The risks presented by legionella make the testing of legionella in water systems and treatment plants essential. With the help of regular testing for legionella, potential and often fatal outbreaks of diseases caused by legionella can be prevented. Due to the growing population, investments towards water treatment plants are increasing, as they are essential for removing hazardous substances and contaminants from water and making it fit for drinking, among other applications. For instance, at present, Austin Water has three water treatment plants that draw water from the Colorado River and treat it to improve water quality and make it fit for drinking.

Future Market Scenario (2024-2031F)

According to the global legionella testing market analysis, the requirement for legionella testing will witness significant increase over the forecast period owing to the increasing need to minimize legionella growth in complex water systems to prevent infections. Due to the rapid expansion of the healthcare sector owing to increasing prevalence of chronic health conditions and rising population, the demand for legionella testing will increase from the sector as healthcare facilities are at a high risk of infection. The growing awareness about the threat of legionella and the risk of colonization in both cold and hot water systems will bolster the market demand in the coming years.

Key Players Landscape and Outlook

The key players in the legionella testing market are BioMerieux SA, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Becton, Dickinson and Company, and Qiagen NV. The growth of the market will be augmented by increasing collaborations and acquisitions. In August 2022, IDEXX laboratories acquired TECTA-PDS, the Canadian water testing company. TECTA specializes in portable instruments that automatically test for enterococci, E. coli, and total coliforms. The TECTA B4 and B16 instruments are capable of providing rapid results to the laboratories. With this expansion, IDEXX expanded their microbiology testing options for in-field and lab-based testing.

Table of Contents

1.Research Methodology

2.Project Scope and Definitions

3.Executive Summary

4.Global Legionella Testing Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2. By Volume
  • 4.2.By Test Type
    • 4.2.1.Urinary Antigen Tests
    • 4.2.2.Direct Fluorescent Antibody Tests
    • 4.2.3.PCR
      • 4.2.3.1.Motorized Devices
      • 4.2.3.2.Non-Motorized Devices
    • 4.2.4.Culture Method
    • 4.2.5.Others
  • 4.3.By Applications
    • 4.3.1.Environmental Testing
    • 4.3.2.Clinical Testing
  • 4.4.By End-User
    • 4.4.1.Hospitals
    • 4.4.2.Clinics
    • 4.4.3.Diagnostic Laboratories
    • 4.4.4.Water Treatment Plants
    • 4.4.5.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.South America
    • 4.5.3.Europe
    • 4.5.4.Asia-Pacific
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Legionella Testing Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Test Type
      • 5.1.2.1.Urinary Antigen Tests
      • 5.1.2.2.Direct Fluorescent Antibody Tests
      • 5.1.2.3.PCR
        • 5.1.2.3.1.Motorized Devices
        • 5.1.2.3.2.Non-Motorized Devices
      • 5.1.2.4.Culture Method
      • 5.1.2.5.Others
    • 5.1.3.By Applications
      • 5.1.3.1.Environmental Testing
      • 5.1.3.2.Clinical Testing
    • 5.1.4.By End-User
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Clinics
      • 5.1.4.3.Diagnostic Laboratories
      • 5.1.4.4.Water Treatment Plants
      • 5.1.4.5.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
        • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Test Type
        • 5.1.5.2.1.Urinary Antigen Tests
        • 5.1.5.2.2.Direct Fluorescent Antibody Tests
        • 5.1.5.2.3.PCR
          • 5.1.5.2.3.1.Motorized Devices
          • 5.1.5.2.3.2.Non-Motorized Devices
        • 5.1.5.2.4.Culture Method
        • 5.1.5.2.5.Others
      • 5.1.5.3.By Applications
        • 5.1.5.3.1.Environmental Testing
        • 5.1.5.3.2.Clinical Testing
      • 5.1.5.4.By End-User
        • 5.1.5.4.1.Hospitals
        • 5.1.5.4.2.Clinics
        • 5.1.5.4.3.Diagnostic Laboratories
        • 5.1.5.4.4.Water Treatment Plants
        • 5.1.5.4.5.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Test Type
  • 6.2.By Applications
  • 6.3.By End-User
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.BioMerieux SA
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Thermo Fisher Scientific Inc.
  • 13.3.Eurofins Scientific SE
  • 13.4.Becton, Dickinson and Company
  • 13.5.Qiagen NV
  • 13.6.Aquacert Ltd.
  • 13.7.Merck KgaA
  • 13.8.Abbott Laboratories
  • 13.9.Pro Lab Diagnostics Inc.
  • 13.10.IDEXX Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 3.Global Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 4.Global Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 5.Global Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Legionella Testing Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 9.North America Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 10.North America Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 11.North America Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Legionella Testing Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 15.United States Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 16.United States Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 17.United States Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 20.Canada Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 21.Canada Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 22.Canada Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 25.Mexico Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 26.Mexico Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 27.Mexico Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 30.Europe Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 31.Europe Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 32.Europe Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Legionella Testing Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 36.Germany Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 37.Germany Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 38.Germany Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 41.France Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 42.France Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 43.France Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 46.Italy Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 47.Italy Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 48.Italy Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 51.United Kingdom Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 52.United Kingdom Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 53.United Kingdom Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 56.Russia Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 57.Russia Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 58.Russia Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 61.Netherlands Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 62.Netherlands Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 63.Netherlands Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 66.Spain Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 67.Spain Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 68.Spain Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 71.Turkey Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 72.Turkey Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 73.Turkey Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 76.Poland Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 77.Poland Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 78.Poland Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 81.South America Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 82.South America Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 83.South America Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Legionella Testing Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 87.Brazil Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 88.Brazil Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 89.Brazil Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 92.Argentina Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 93.Argentina Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 94.Argentina Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 97.Asia-Pacific Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 98.Asia-Pacific Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 99.Asia-Pacific Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Legionella Testing Market Share (%), By Country, 2017-2031F
  • Figure 101.India Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 103.India Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 104.India Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 105.India Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 108.China Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 109.China Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 110.China Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 113.Japan Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 114.Japan Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 115.Japan Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 118.Australia Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 119.Australia Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 120.Australia Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 123.Vietnam Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 124.Vietnam Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 125.Vietnam Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 128.South Korea Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 129.South Korea Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 130.South Korea Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 133.Indonesia Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 134.Indonesia Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 135.Indonesia Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 138.Philippines Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 139.Philippines Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 140.Philippines Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 143.Middle East & Africa Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 144.Middle East & Africa Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 145.Middle East & Africa Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Legionella Testing Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 149.Saudi Arabia Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 150.Saudi Arabia Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 151.Saudi Arabia Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 154.UAE Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 155.UAE Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 156.UAE Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Legionella Testing Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
  • Figure 159.South Africa Legionella Testing Market Share (%), By Test Type, 2017-2031F
  • Figure 160.South Africa Legionella Testing Market Share (%), By Applications, 2017-2031F
  • Figure 161.South Africa Legionella Testing Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Test Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023